Correction Volume 16, Issue 17 pp 12428
Correction for: PKMYT1, exacerbating the progression of clear cell renal cell carcinoma, is implied as a biomarker for the diagnosis and prognosis
- 1 The Ministry of Education Key Laboratory of Laboratory Medical Diagnostics, The College of Laboratory Medicine, Chongqing Medical University, Chongqing 400016, China
- 2 Department of Urology, The First Affiliated Hospital of Anhui Medical University, Hefei, China
- 3 Anhui Province Key Laboratory of Genitourinary Diseases, Anhui Medical University, Hefei, China
- 4 The Institute of Urology, Anhui Medical University, Hefei, China
Received: September 10, 2024 Accepted: September 10, 2024 Published: September 15, 2024
https://doi.org/10.18632/aging.206113How to Cite
Copyright: © 2024 Chen et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
This article has been corrected: The authors forgot to add one more source of funding from Scientific and Technological Research Program of Chongqing Municipal Education Commission Grant No. KJQN202100418. The corrected text is presented below.
Funding
This study was funded by Natural Science Foundation of Chongqing Science and Technology Bureau (cstc2021jcyj-msxm0317) to J.C., the Scientific and Technological Research Program of Chongqing Municipal Education Commission (Grant No. KJQN202100418) to J.C., the National Natural Science Foundation of China (82030065) to Q.Z., Scientific Research Foundation of the Institute for Translational Medicine of Anhui Province (2017ZHYX02) to C.Z.L. and Key project of Natural Science Research project of Anhui Province (KJ2019A0280) and National Natural Science Foundation of China (81902584) to H.B.X.